Find A Portfolio/Ticker
Comparison Box
FSMEX: Fidelity Select Medical Equip & Systems (MUTUAL FUND)
Basic Info 64.65 0.71(1.09%) February 08
Asset Class: | Health |
MyPlanIQ Rating: | (76%) |
Start Date: | 06/17/1998 |
Last Dividend Date: | 04/08/2022 |
12-Mo. Yield | 8.59% |
Expenses | 0.84% |
Sign up to get fund ranking change alerts |
Performance Analytics (As of 02/03/2023)
Not up-to-date? TryLast 1 Week* | YTD*(2023) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | Inception** | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AR(%) | -0.7 | 5.0 | -7.0 | 8.5 | 13.8 | 16.6 | 13.5 | 14.0 | -23.7 | 19.8 | 30.0 | 29.6 | 16.2 | 26.6 | 8.7 | 7.1 | 26.7 | 41.3 | 15.6 | -3.4 | 12.9 | 32.6 | -23.4 | 17.9 | 4.1 | 7.6 | 17.5 | 33.4 | -6.2 | 0.3 | 50.4 | 10.7 | 21.5 |
SR | NA | 5.74 | -0.24 | 0.32 | 0.51 | 0.8 | NA | 0.67 | -0.84 | 1.14 | 0.91 | 1.69 | 0.78 | 2.48 | 0.49 | 0.42 | 1.31 | 3.44 | 1.13 | -0.14 | 0.77 | 1.53 | -0.81 | 1.15 | 0.07 | 0.57 | 1.29 | 2.34 | -0.34 | -0.11 | 2.03 | 0.39 | 1.7 |
DD(%) | NA | 3.1 | 25.0 | 35.2 | 35.2 | 35.2 | NA | 40.2 | 33.0 | 11.9 | 33.0 | 8.8 | 20.6 | 4.3 | 14.7 | 15.7 | 9.1 | 4.2 | 9.1 | 23.2 | 19.0 | 19.6 | 40.2 | 7.4 | 13.5 | 6.1 | 12.7 | 6.7 | 25.6 | 19.3 | 8.8 | 16.2 | 18.0 |
SD(%) | NA | 17.8 | 29.3 | 27.4 | 24.1 | 20.4 | NA | 19.5 | 30.0 | 17.4 | 32.4 | 16.7 | 19.1 | 10.5 | 17.2 | 17.0 | 20.3 | 12.0 | 13.9 | 24.5 | 16.5 | 21.3 | 29.9 | 13.0 | 11.8 | 9.6 | 12.8 | 14.0 | 21.7 | 18.8 | 22.8 | 19.3 | 23.3 |
TR | NA | 1.27 | -0.06 | 0.08 | 0.11 | 0.16 | NA | 0.13 | -0.2 | 0.18 | 0.27 | 0.27 | 0.14 | 0.37 | 0.1 | 0.08 | 0.28 | 0.43 | 0.13 | -0.03 | 0.11 | 0.32 | -0.25 | 0.15 | 0.01 | 0.06 | 0.16 | 0.39 | -0.08 | -0.02 | 0.5 | 0.07 | 0.35 |
Alpha(%) | NA | 0.32 | -0.07 | -0.01 | 0.01 | 0.01 | NA | 0.01 | -0.11 | 0.02 | 0.06 | 0.02 | 0.06 | 0.05 | 0.07 | -0.02 | 0.0 | 0.0 | -0.01 | -0.07 | 0.02 | 0.04 | -0.03 | 0.05 | -0.02 | -0.02 | 0.03 | 0.04 | 0.02 | 0.04 | -0.01 | 0.02 | -0.01 |
Beta(%) | NA | 0.8 | 1.25 | 1.11 | 1.09 | 1.02 | NA | 1.02 | 1.29 | 1.1 | 1.09 | 1.06 | 1.04 | 0.71 | 0.85 | 0.93 | 0.96 | 0.97 | 1.2 | 1.3 | 1.15 | 1.02 | 0.97 | 1.0 | 0.99 | 0.88 | 1.03 | 0.84 | 0.95 | 1.08 | 0.92 | 1.04 | 1.13 |
RS | NA | 0.24 | 0.74 | 0.74 | 0.74 | 0.69 | NA | 0.72 | 0.77 | 0.5 | 0.87 | 0.73 | 0.74 | 0.45 | 0.64 | 0.84 | 0.37 | 0.72 | 0.74 | 0.92 | 0.8 | 0.77 | 0.86 | 0.7 | 0.6 | 0.62 | 0.65 | 0.71 | 0.77 | 0.78 | 0.6 | 0.66 | 0.79 |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 06/17/1998
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (Vanguard Health Care Inv) (97%)
- HGHAX (Hartford Healthcare A) (77%)
- FSMEX (Fidelity Select Medical Equip & Systems) (76%)
- FBIOX (Fidelity Select Biotechnology) (76%)
- FBTIX (Fidelity Advisor Biotechnology I) (76%)
- FSHCX (Fidelity Select Medical Delivery Port) (73%)
- FSPHX (Fidelity Select Health Care) (73%)
- FHCIX (Fidelity Advisor Health Care I) (72%)
- SHSSX (BlackRock Health Sciences Opps Inst) (65%)
- MEDRX (Kinetics Medical No Load) (65%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR ETF) (96%)
- BBH (Market Vectors Biotech ETF) (94%)
- IBB (iShares Nasdaq Biotechnology) (94%)
- PPH (Market Vectors Pharmaceutical ETF) (93%)
- FBT (First Trust NYSE Arca Biotech ETF) (91%)
- FXH (First Trust Health Care AlphaDEX ETF) (90%)
- IHE (iShares US Pharmaceuticals) (88%)
- IHF (iShares US Healthcare Providers) (87%)
- IHI (iShares US Medical Devices) (87%)
Best Closed End Funds
- BME (BlackRock Health Sciences) (100%)
- GRX (Gabelli Healthcare & Wellness Trust) (99%)
- HQH (H&Q Healthcare Investors) (98%)
- HQL (H&Q Life Sciences Investors) (98%)